Ontology highlight
ABSTRACT:
SUBMITTER: Lloyd S
PROVIDER: S-EPMC4074950 | biostudies-other | 2014 Jun
REPOSITORIES: biostudies-other
Journal of gastrointestinal oncology 20140601 3
Chemoradiotherapy (CRT) has an important role in the treatment of esophageal cancer in both the inoperable and the pre-operative settings. Pre-operative chemoradiation therapy is generally given to 41.4-50.4 Gy with platinum or paclitaxel based chemotherapy. The most common definitive dose in the U.S. is 50-50.4 Gy. New advances in CRT for esophageal cancer have come from looking for ways to minimize toxicity and maximize efficacy. Recent investigations for minimizing toxicity have focused advan ...[more]